A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...
Ulcerative colitis and colorectal cancer have a connection, but you can lower your risk of the latter through regular cancer ...
People with inflammatory bowel disease, like ulcerative colitis, are 2 to 3 times more likely to develop blood clots than ...
People with ulcerative colitis, a form of IBD, who were taking the new drug Omvoh and achieved clinical remission after 1 ...
Ischemic Colitis occurs when blood flow to part of the colon is reduced or blocked, causing inflammation and potential tissue damage. Symptoms can range from mild abdominal discomfort to severe pain ...
Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...
Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...
Eli Lilly’s ulcerative colitis (UC) treatment, Omvoh (mirikizumab), has shown sustained positive outcomes in patients with ...
What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...
LA Times Studios produces content by working closely with scientists and healthcare experts as well as sourcing scholarly-reviewed medical and science journals and does not involve the Los Angeles ...